CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Clinical trials for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) explained in plain language.
Never miss a new study
Get alerted when new CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) trials appear
Sign up with your email to follow new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to intercept psychosis before it starts
Disease control Recruiting nowThis study is testing a new drug, MT1988, to see if it can improve memory, thinking skills, and reduce early symptoms in young people (aged 17-30) who are at high risk for developing psychosis. Participants will take the drug or a placebo twice daily for 8 weeks while researchers…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: PHASE1, PHASE2 • Sponsor: Monument Therapeutics Limited • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Can computer games help prevent psychosis in At-Risk youth?
Disease control Recruiting nowThis study is testing whether a 12-week brain training program can help young people who are at high risk for developing psychosis. Participants will either do fun, computer-based thinking exercises or receive standard mental health support. The goal is to see if the training imp…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Virtual lifeline: can online therapy stop psychosis before it starts?
Disease control Recruiting nowThis study is testing whether therapy delivered through video calls can help teens and young adults who show early warning signs of psychosis. Researchers want to see if online group, family, or individual therapy can reduce symptoms, improve daily functioning, and possibly preve…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Researchers listen to young minds: what happens during mindfulness for psychosis risk?
Knowledge-focused Recruiting nowThis study aims to understand what it's like for young people at risk for psychosis to participate in mindfulness group sessions. Researchers will interview 20 participants aged 15-30 who have already completed mindfulness training. The goal is to learn about their experiences an…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC